Evidence map›Paper›PMID 30282614›Full record

ArticleBiochimica et biophysica acta. Proteins and proteomics2018

Ordered opening of LDL receptor binding domain of human apolipoprotein E3 revealed by hydrogen/deuterium exchange mass spectrometry and fluorescence spectroscopy.

Liping Yang, Roy V Hernandez, Tuyen N Tran, Sasidhar Nirudodhi, Wendy H J Beck, Claudia S Maier, Vasanthy Narayanaswami

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Proteins and proteomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Liping YangDepartment of Chemistry, Oregon State University, Corvallis, OR 97331, USA. Electronic address: yangli@science.oregonstate.edu.
Roy V HernandezDepartment of Chemistry and Biochemistry, California State University Long Beach, Long Beach, California 90840, USA.
Tuyen N TranEdward Via College of Osteopathic Medicine, Auburn Campus, 910 South Donahue Drive, Auburn, AL 36832, United States.
Sasidhar NirudodhiDepartment of Chemistry, Oregon State University, Corvallis, OR 97331, USA.
Wendy H J BeckDepartment of Chemistry and Biochemistry, California State University Long Beach, Long Beach, California 90840, USA.
Claudia S MaierDepartment of Chemistry, Oregon State University, Corvallis, OR 97331, USA. Electronic address: claudia.maier@oregonstate.edu.
Vasanthy NarayanaswamiDepartment of Chemistry and Biochemistry, California State University Long Beach, Long Beach, California 90840, USA. Electronic address: vas.narayanaswami@csulb.edu.
California State University, Long Beach · USOregon State University · USEdward Via College of Osteopathic Medicine · US

Funding

Transendothelial transport mediated modulations to the High Density LipoproteinSC3GM105561 · NIGMS · CALIFORNIA STATE UNIVERSITY LONG BEACH · PI NARAYANASWAMI, VASANTHY · 2013 to 2021
$876k
Short Term Research Education Program to Increase Diversity in Health ResearchR25HL096365 · NHLBI · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI LUBIN, BERTRAM HAROLD, NARAYANASWAMI, VASANTHY · 2009 to 2013
$818k
Ion Mobility Time-of-flight Mass Spectrometry SystemS10RR025628 · NCRR · OREGON STATE UNIVERSITY · PI MAIER, CLAUDIA S, STEVENS, JAN FREDERIK · 2009 to 2009
$440k
NCRR NIH HHS S10 RR025628NHLBI NIH HHS R25 HL096365NIGMS NIH HHS SC3 GM105561NIH HHS GM105561NIH HHS HL096365NIH HHS S10 RR025628
6 · The paper itself

Abstract

Apolipoprotein E3 (apoE3) is an exchangeable apolipoprotein that plays a critical role in cholesterol homeostasis. The N-terminal (NT) domain of apoE3 (residues 1-191) is folded into a helix bundle comprised of 4 amphipathic α-helices: H1, H2, H3 and H4, flanked by flexible helices N1 and N2, and Hinge Helix 1 (Hinge H1), at the N-and C-terminal sides of the helix bundle, respectively. The NT domain plays a critical role in binding to the low density lipoprotein receptor (LDLR), which eventually leads to lowering of plasma cholesterol levels. In order to be recognized by the LDLR, the helix bundle has to open and undergo a conformational change. The objective of the study was to understand the mechanism of opening of the helix bundle. Hydrogen/deuterium exchange mass spectrometry (HDX-MS) revealed that apoE3 NT domain adopts several disordered and unfolded regions, with H2 exhibiting relatively little protection against exchange-in compared to H1, H3, and H4. Site-directed fluorescence labeling indicated that H2 not only has the highest degree of solvent exposure but also the most flexibility in the helix bundle. It also indicated that the lipoprotein behavior of H1 was significnatly different from that of H2, H3 and H4. These results suggest that the opening of the helix bundle is likely initiated at the flexible end of H2 and the loop linking H2/H3, and involves movement of H2/H3 away from H1/H4. Together, these observations offer mechanistic insight suggesting a regulated helix bundle opening of apoE3 NT domain can be triggered by lipid binding.

Indexed as

Mass SpectrometrySpectrometry, FluorescenceApolipoproteins EBinding SitesCircular DichroismDeuteriumEscherichia coliHumansHydrogenLipid MetabolismProtein BindingProtein ConformationReceptors, LDLApoE protein, humanApolipoproteins EDeuteriumHydrogenLDLR protein, humanReceptors, LDLApolipoprotein E3Fluorescence spectroscopyHelix bundle openingHydrogen deuterium exchange mass spectrometryLDL receptorLipoprotein binding

Identifiers

PMID30282614
PMCPMC6407697
OpenAlexW2888550164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.